| For: |
Altintas E, Sezgin O, Ulu O, Aydin O, Camdeviren H. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/1656.htm |
| Number | Citing Articles |
| 1 |
Jian Zou, Jie Dong, Xiaofeng Yu. Meta‐Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First‐Line Therapy for Helicobacter pylori Eradication. Helicobacter 2009; 14(5) doi: 10.1111/j.1523-5378.2009.00716.x
|
| 2 |
Xiaoyu Wan, Heng Jiang, Kangning Peng. Comparison of Efficacy on First-Line Helicobacter Pylori Eradication Between Potassium-Competitive Acid Blocker (P-CAB)-Based Therapies Versus Proton-Pump Inhibitor (PPI)-Based Therapies. Journal of Clinical Gastroenterology 2025; doi: 10.1097/MCG.0000000000002190
|
| 3 |
Shahrokh Mousavi, Jafar Toussy, Siamak Yaghmaie, Mehrdad Zahmatkesh. Azithromycin in one week quadruple therapy for <italic>H pylori</italic> eradication in Iran. World Journal of Gastroenterology 2006; 12(28): 4553-4556 doi: 10.3748/wjg.v12.i28.4553
|
| 4 |
Mohammad Minakari, Amir Hosein Davarpanah Jazi, Ahmad Shavakhi, Neda Moghareabed, Farinaz Fatahi. A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second‐Line Therapy in Patients With Helicobacter pylori Infection. Helicobacter 2010; 15(2) doi: 10.1111/j.1523-5378.2009.00739.x
|
| 5 |
Saghi Riahizadeh, Reza Malekzadeh, Shahram Agah, Nasrin Zendehdel, Rasoul Sotoudehmanesh, Naser Ebrahimi‐Dariani, Akram Pourshams, Homayoon Vahedi, Javad Mikaeli, Morteza Khatibian, Sadegh Massarrat. Sequential Metronidazole‐Furazolidone or Clarithromycin‐Furazolidone Compared to Clarithromycin‐Based Quadruple Regimens for the Eradication of Helicobacter pylori in Peptic Ulcer Disease: A Double‐Blind Randomized Controlled Trial. Helicobacter 2010; 15(6) doi: 10.1111/j.1523-5378.2010.00798.x
|
| 6 |
Geun Am Song, Dae Hwan Kang, Chul Soo Song, Seung Keun Park, Ung Suk Yang, Jong Yun Cheong, Gwang Ha Kim, Hyung Wook Kim. <italic>H pylori</italic> eradication: A randomized prospective study of triple therapy with or without ecabet sodium. World Journal of Gastroenterology 2008; 14(6): 908-912 doi: 10.3748/wjg.14.908
|
| 7 |
A. Zullo, V. De Francesco, G. Scaccianoce, C. Hassan, A. Panarese, D. Piglionica, C. Panella, S. Morini, E. Ierardi. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: A randomised, multicentre study. Digestive and Liver Disease 2005; 37(7) doi: 10.1016/j.dld.2005.01.017
|
| 8 |
F. DI MARIO, G. ARAGONA, N. DAL BÓ, L. CAVALLARO, V. MARCON, P. OLIVIERI, E. BENEDETTI, N. ORZÈS, R. MARIN, G. TAFNER, F. CHILOVI, R. DE BASTIANI, F. FEDRIZZI, M. FRANCESCHI, M. H. SALVAT, F. MONICA, L. PIAZZI, F. VALIANTE, U. VECCHIATI, G. M. CAVESTRO, G. COMPARATO, V. IORI, M. MAINO, G. LEANDRO, A. PILOTTO, M. RUGGE, A. FRANZÈ. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Alimentary Pharmacology & Therapeutics 2006; 23(8) doi: 10.1111/j.1365-2036.2006.02851.x
|
| 9 |
Yildiran Songür, Altuğ Şenol, Ayşe Balkarli, Abdülkadir Baştürk, Süreyya Çerçi. Triple or Quadruple Tetracycline-Based Therapies Versus Standard Triple Treatment for Helicobacter pylori Treatment. The American Journal of the Medical Sciences 2009; 338(1) doi: 10.1097/MAJ.0b013e31819c7320
|
| 10 |
J. P. GISBERT, J.‐L. GISBERT, S. MARCOS, I. JIMENEZ‐ALONSO, R. MORENO‐OTERO, J. M. PAJARES. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients. Alimentary Pharmacology & Therapeutics 2008; 27(4) doi: 10.1111/j.1365-2036.2007.03573.x
|
| 11 |
Orhan Sezgin, Engin Altınta5, Erdinç Nayır, Enver Üçbilek. A Pilot Study Evaluating Sequential Administration of a PPI–Amoxicillin Followed by a PPI–Metronidazole–Tetracycline in Turkey. Helicobacter 2007; 12(6) doi: 10.1111/j.1523-5378.2007.00547.x
|
| 12 |
David Y. Graham. Implications of the paradigm shift in management of Helicobacter pylori infections. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231160858
|
| 13 |
Pedro Cortés, Alfred D. Nelson, Yan Bi, Fernando F. Stancampiano, Loren P. Murray, George G.A. Pujalte, Victoria Gomez, Dana M. Harris. Treatment Approach of Refractory Helicobacter pylori Infection: A Comprehensive Review. Journal of Primary Care & Community Health 2021; 12 doi: 10.1177/21501327211014087
|
| 14 |
Nicola de Bortoli, Giulia Leonardi, Eugenio Ciancia, Andrea Merlo, Massimo Bellini, Francesco Costa, Maria Gloria Mumolo, Angelo Ricchiuti, Fabrizio Cristiani, Stefano Santi, Mauro Rossi, Santino Marchi. Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy Versus Triple Therapy Plus Lactoferrin and Probiotics. The American Journal of Gastroenterology 2007; 102(5) doi: 10.1111/j.1572-0241.2007.01085.x
|
| 15 |
A. Zullo, V. De Francesco, G. Scaccianoce, G. Manes, C. Efrati, C. Hassan, G. Maconi, D. Piglionica, C. Cannaviello, C. Panella, S. Morini, E. Ierardi. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre study. Digestive and Liver Disease 2007; 39(9) doi: 10.1016/j.dld.2007.05.021
|
| 16 |
Kiarash Ghazvini, Hossein Kamali, Seyed-Abolfazl Hosseininasab-nodoushan, Masoud Keikha. The CYP2C19 polymorphisms effects on H. pylori cure rate in proton pump inhibitor-based therapeutic regimens: An updated meta-analysis. Gene Reports 2021; 25 doi: 10.1016/j.genrep.2021.101340
|
| 17 |
Natalia MOLODOZHNIKOVA, Anna BERESTOVA, Iza BERECHIKIDZE, Dariya SHORINA, Olga MORUGINA. Changes in the tissue elements of the gastric mucosa interacting with different strains of <i>Helicobacter pylori</i>, taking into consideration the patient’s genotype. Bioscience of Microbiota, Food and Health 2024; 43(3) doi: 10.12938/bmfh.2023-070
|
| 18 |
E. G. GIANNINI, C. BILARDI, P. DULBECCO, M. MAMONE, M. L. SANTI, R. TESTA, C. MANSI, V. SAVARINO. A study of 4‐ and 7‐day triple therapy with rabeprazole, high‐dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2006; 23(2) doi: 10.1111/j.1365-2036.2006.02756.x
|
| 19 |
Jian Zou, Xiao-Feng Yu, Jie Dong. Azithromycin-containing <italic>versus</italic> standard triple therapy for <italic>Helicobacter pylori</italic> eradication: A meta-analysis. World Journal of Gastroenterology 2009; 15(48): 6102-6110 doi: 10.3748/wjg.15.6102
|
| 20 |
Orhan Sezgin, Engin Altıntaş, Enver Üçbilek, Anıl Tombak, Burçin Tellioǧlu. Low Efficacy Rate of Moxifloxacin‐Containing Helicobacter pylori Eradication Treatment: In an Observational Study in a Turkish Population. Helicobacter 2007; 12(5) doi: 10.1111/j.1523-5378.2007.00535.x
|
| 21 |
Peter Bytzer, Colm O'Morain. Treatment of Helicobacter pylori. Helicobacter 2005; 10(s1) doi: 10.1111/j.1523-5378.2005.00333.x
|
| 22 |
Javier P. Gisbert. Review: Second-line rescue therapy of Helicobacter pylori infection. Therapeutic Advances in Gastroenterology 2009; 2(6) doi: 10.1177/1756283X09347109
|
| 23 |
Huseyin Alkim, Mustafa Iscan, Feriha Oz. Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey. Libyan Journal of Medicine 2011; 6(1) doi: 10.3402/ljm.v6i0.8412
|
| 24 |
Recep ÇAĞLAR. Helicobacter pylori Eradikasyonunda Kullanılan Kombine Tedavilerin Etkinliklerinin Karşılaştırılması. Sağlık Bilimlerinde Değer 2023; 13(1) doi: 10.33631/sabd.1210607
|
| 25 |
F. Perna, A. Zullo, C. Ricci, C. Hassan, S. Morini, D. Vaira. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance. Digestive and Liver Disease 2007; 39(11) doi: 10.1016/j.dld.2007.06.016
|
| 26 |
Abdurrahman Kadayifci, Hakan Buyukhatipoglu, M. Cemil Savas, Ilkay Simsek. Eradication of Helicobacter pylori with triple therapy:An epidemiologic analysis of trends in Turkey over 10 years. Clinical Therapeutics 2006; 28(11) doi: 10.1016/j.clinthera.2006.11.011
|
| 27 |
Francis Mégraud. Update on therapeutic options for Helicobacter pylori-related diseases. Current Infectious Disease Reports 2005; 7(2) doi: 10.1007/s11908-005-0071-4
|
| 28 |
Edoardo G. Giannini, Claudio Bilardi, Pietro Dulbecco, Mario Mamone, Maria L. Santi, Roberto Testa, Carlo Mansi, Vincenzo Savarino. Can Helicobacter pylori Eradication Regimens be Shortened in Clinical Practice? An Open-label, Randomized, Pilot Study of 4 and 7-day Triple Therapy With Rabeprazole, High-dose Levofloxacin, and Tinidazole. Journal of Clinical Gastroenterology 2006; 40(6) doi: 10.1097/00004836-200607000-00010
|
| 29 |
Johnny Parrales, Byron Landivar, Manuel Moncayo, Carlos Robles-Medranda, Carlos Robles-Jara. Is a 7-day <italic>Helicobater pylori</italic> treatment enough for eradication and inactivation of gastric inflammatory activity?. World Journal of Gastroenterology 2008; 14(18): 2838-2843 doi: 10.3748/wjg.14.2838
|
| 30 |
R. Dertli, M. Asıl, Y. Atayan, U. Coşar, R. Yolaçan, M. Bıyık, M. Keskin. Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04417-6
|
| 31 |
J. P. GISBERT, M. FERNÁNDEZ‐BERMEJO, J. MOLINA‐INFANTE, B. PÉREZ‐GALLARDO, A.‐B. PRIETO‐BERMEJO, J.‐M. MATEOS‐RODRÍGUEZ, P. ROBLEDO‐ANDRÉS, G. GONZÁLEZ‐GARCÍA. First‐line triple therapy with levofloxacin for Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2007; 26(3) doi: 10.1111/j.1365-2036.2007.03384.x
|
| 32 |
Angelo Zullo, Vincenzo De Francesco, Cesare Hassan, Sergio Morini, Dino Vaira. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007; 56(10) doi: 10.1136/gut.2007.125658
|
| 33 |
YUPING YUAN, QINYI WU, GUOXIANG CHENG, XUEFANG LIU, SIGUO LIU, JUAN LUO, AIMIN ZHANG, LI BIAN, JIANQUAN CHEN, JIAJUN LV, XIANGQIAN DONG, GANG YANG, YUNZHEN ZHU, LANQING MA. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori. International Journal of Molecular Medicine 2015; 36(2) doi: 10.3892/ijmm.2015.2251
|
| 34 |
Fu-Lian Hu, Hong Cheng. Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori. World Journal of Gastroenterology 2009; 15(7): 860-864 doi: 10.3748/wjg.15.860
|
| 35 |
Jian-Zhong Zhang, Yan-Li Xu, Feng-Zhe Jin, Hong Ouyang, Qiu-Long Ding, Xu-Peng Chen, Jian-Sheng Wu, Guo-Fa Jiang, Hui-Min Tu, Zhi-Yong Wang, Guang-Lan Chen, Mi-Zu Jiang, Yue-Feng Tong, Xing-Hua Wang, Xiao-Feng Zhang, Wei Shao, Xin-Jian Zhu, Wu-Heng Tang, Zheng-Chao Shi, Jun-Liang Mao, Ji-Bo Mao, Zi-Zhong Ji, Jia-Kun Zhang, Qun-Ying Wang, Lang Lin, Feng Guo, Hong-Zhang Li, Ning-Min Yang, You-Ming Li, Ya-Nan Gong. Centralized isolation of <italic>Helicobacter pylori</italic> from multiple centers and transport condition influences. World Journal of Gastroenterology 2015; 21(3): 944-952 doi: 10.3748/wjg.v21.i3.944
|
| 36 |
Rajmohan Rammohan, Sai Greeshma Magam, Melvin Joy, Dilman Natt, Achal Patel, Abhishek Tadikonda, Jiten Desai, Susan Bunting , Robert M Yost , Olawale Akande, Paul Mustacchia. Unpacking the Racial Gap: Helicobacter pylori Infection Clearance Among Different Racial Groups. Cureus 2023; doi: 10.7759/cureus.43080
|
| 37 |
Jian Zou, Jie Dong, Xiao Feng Yu. Meta‐Analysis: The Effect of Supplementation with Lactoferrin on Eradication Rates and Adverse Events During Helicobacter pylori Eradication Therapy. Helicobacter 2009; 14(2) doi: 10.1111/j.1523-5378.2009.00666.x
|
| 38 |
Javier P Gisbert. “Rescue” regimens after <italic>Helicobacter pylori</italic> treatment failure. World Journal of Gastroenterology 2008; 14(35): 5385-5402 doi: 10.3748/wjg.14.5385
|
| 39 |
F. Iacopini, P. Crispino, O.A. Paoluzi, A. Consolazio, R. Pica, M. Rivera, D. Palladini, F. Nardi, P. Paoluzi. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication. Digestive and Liver Disease 2005; 37(8) doi: 10.1016/j.dld.2005.03.007
|
| 40 |
Mojgan Jalalzadeh, Morteza Nazarian, Jamshid Vafaeimanesh, Fatemeh Mirzamohammadi. Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in hemodialysis Patients. Nephro-Urology Monthly 2012; 4(3) doi: 10.5812/numonthly.2794
|
| 41 |
David Y Graham, Lori Fischbach.
Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59(8) doi: 10.1136/gut.2009.192757
|